Diane Bouis, PhD, MBA, is a vascular scientist turned business leader, currently serving as CEO of Microvascular Health Solutions a wholly owned subsidiary of Bioregenx,
and Fundraising Board Member of BioMEMS Diagnostics. 

She is an alternate member of an oncology institutional review board (IRB) at University of Michigan, and a mentor in several biomedical/ medtech accelerator programs.

Prior roles include, US Director for MedTech World, US Director for MedTech Innovator, the largest medtech accelerator in the world. Dr Bouis obtained her PhD at the University of Groningen, The Netherlands working on angiogenesis (blood vessel growth) in cancer and her postdoctoral fellowship at the University of Michigan on atherosclerosis in heart attack and stroke.

She transitioned into business with an MBA from University of Michigan and has extensive experience managing startup portfolios through prior roles as Innovation Manager at the University of Michigan's Innovation Partnerships Startup Incubator and as an innovation consultant with The Inovo Group.

Dr Bouis is a frequent speaker on medtech/ biotech/ health-tech innovation, investment and go to market strategy, incubators and accelerators, mentorship, leadership and growing strong teams.

Besides her global roles, this native of France is a staunch supporter of her chosen Midwest startup home ecosystem and advisor to and investor in Michigan biomedical startups. She is in the early phase of building a medtech founder residency fund (still in stealth mode).